Home NDC 71921-210 Valganciclovir
Product NDC 71921-210
11-digit product format 719210210
Labeler code 71921
Product ID 71921-210_cc6c4939-7908-439c-b1b8-6b52e826c7a5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Valganciclovir
Dosage form POWDER, FOR SOLUTION
Route ORAL
Labeler Florida Pharmaceutical Products, LLC
Application ANDA216317
Marketing category ANDA
Marketing start 2023-07-01
Substance VALGANCICLOVIR
Active strength 50 mg/mL
Pharmacologic classes Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Valganciclovir
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength VALGANCICLOVIR 50 mg/mL
Harmonized Identifiers# Field, Values table Field Values Unii GCU97FKN3R Rxcui 863559
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71921-210-12 Valganciclovir 100 mL in 1 BOTTLE POWDER, FOR SOLUTION 100 1 71921-210-12 Valganciclovir 1 in 1 CARTON POWDER, FOR SOLUTION 1 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71921-210 VALGANCICLOVIR POWDER, FOR SOLUTION [FLORIDA PHARMACEUTICAL PRODUCTS, LLC] 1 Current NDC, 2 package rows 20230714_cc6c4939-7908-439c-b1b8-6b52e826c7a5.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 71921-210-12 71921021012 1 BOTTLE in 1 CARTON (71921-210-12) / 100 mL in 1 BOTTLE 1 bottle 2023-07-01 No No Historical